Please join us for the first #TumorBoardTuesday of 2023!!

@tompowles1 @PBarataMD @FedGhali @TomJayram @arnabguonc @sonpavde @nataliagandur @LauraEsfeller @dawood_findakly @mtsiatas @RCCadvocate @AmandaNizamMD @QingZhangLab @PavlosMsaouel @OAlhalabiMD @uwradonc @UWMedicine

👉🏽#CME🔗 http://integrityce.com/tbt

📊1 way #TumorBoardTuesday gathers input is with polls, so be sure to tick your box!

👨🏻‍⚕️Before @PGrivasMDPhD @rafee_talukder take us through treatment options for mutated advanced #UrothelialCancer

🧐Tell us where you are in your 🩺journey
👇🏽👇🏽

❄️The above & upcoming #TumorBoardTuesday discussion with moderator @PGrivasMDPhD @rafee_talukder is provided by @IntegrityCE

❄️Supported by educational grants from @AstraZeneca, Exelixis, & Merck Sharp & Dohme Corp

❄️More info about our free CME & MOC: http://integrityce.com/tbt

#TumorBoardTuesday #PreTest Q1️⃣
Free #CME🔗:http://integrityce.com/tbt

🤔B4⃣ @PGrivasMDPhD @rafee_talukder🗣️FGFR3 as a🎯in met Bladder Ca, test your🧠with these 2❓s:

Which💊would you choose for a 74yo♂️ with G2 neuropathy & FGFR3 mut➕met bladder Ca s/p Gem-cis⏩maint avelumab❓